Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Randomized, Double-blind, Placebo-controlled Trial to Investigate the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05194007
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:07.286816+00:00
Published At
2024-11-20T00:00:00+00:00
Record Updated At
2024-11-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ulcerative Colitis Chronic Mild", "Ulcerative Colitis Chronic Moderate", "Crohn Colitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-20"
protocolSection.identificationModule.nctId
"NCT05194007"
protocolSection.identificationModule.officialTitle
"A Pilot Randomized, Double-blind, Placebo-controlled Trial to Investigate the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ulcerative Colitis Chronic Mild (protocolSection.conditionsModule.conditions)
  • Ulcerative Colitis Chronic Moderate (protocolSection.conditionsModule.conditions)
  • Crohn Colitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.